156 related articles for article (PubMed ID: 10180337)
1. Looking beyond the formulary budget in cost-benefit analysis.
Cohen LJ
Am J Manag Care; 1997 Feb; 3 Suppl():S11-7. PubMed ID: 10180337
[TBL] [Abstract][Full Text] [Related]
2. Pharmacoeconomics of antipsychotic drug therapy.
Hargreaves WA; Shumway M
J Clin Psychiatry; 1996; 57 Suppl 9():66-76. PubMed ID: 8823354
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the cost effectiveness of newer psychotropic medications.
Viale GL
Am J Manag Care; 1997 Feb; 3 Suppl():S7-10. PubMed ID: 10180341
[TBL] [Abstract][Full Text] [Related]
5. Generic replacement of clozapine: a simple decision model from a Canadian perspective.
Layton S; Barbeau M
Curr Med Res Opin; 2004 Apr; 20(4):453-9. PubMed ID: 15119982
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacoeconomic review of the use of injectable long-acting risperidone].
Bartkó G; Fehér L
Neuropsychopharmacol Hung; 2005 Dec; 7(4):199-207. PubMed ID: 16496485
[TBL] [Abstract][Full Text] [Related]
7. The treatment of psychosis: resetting the drug cost 'thermostat'.
Reid WH
J Clin Psychiatry; 1994 Sep; 55 Suppl B():166-8. PubMed ID: 7961565
[TBL] [Abstract][Full Text] [Related]
8. Formulary decisions and health economics.
Glazer WM
J Clin Psychiatry; 1998; 59 Suppl 19():23-9. PubMed ID: 9847049
[TBL] [Abstract][Full Text] [Related]
9. New vs. old antipsychotics: the Texas experience.
Reid WH
J Clin Psychiatry; 1999; 60 Suppl 1():23-5; discussion 28-30. PubMed ID: 10037167
[TBL] [Abstract][Full Text] [Related]
10. Treatment of schizophrenia: let's talk dollars and sense.
Buckley PF
Am J Manag Care; 1998 Mar; 4(3):369-83. PubMed ID: 10178499
[TBL] [Abstract][Full Text] [Related]
11. Each of the following statements about the newer medications for schizophrenia, risperidone (risperidol) and clozapine (clozaril), is true, except: Patients receiving risperidone are at risk for agranulocytosis.
Can Fam Physician; 1995 Oct; 41():1678, 1680. PubMed ID: 8829578
[No Abstract] [Full Text] [Related]
12. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
13. A pharmacoeconomic analysis of atypical antipsychotics and haloperidol in first-episode schizophrenic patients in taiwan.
Gau SS; Chung CH; Gau CS
J Clin Psychopharmacol; 2008 Jun; 28(3):271-8. PubMed ID: 18480683
[TBL] [Abstract][Full Text] [Related]
14. The pharmacoeconomics of clozapine: a review.
Meltzer HY; Cola PA
J Clin Psychiatry; 1994 Sep; 55 Suppl B():161-5. PubMed ID: 7961564
[TBL] [Abstract][Full Text] [Related]
15. Perspective and the measurement of costs and benefits for cost-effectiveness analysis in schizophrenia.
Meltzer D
J Clin Psychiatry; 1999; 60 Suppl 3():32-5; discussion 36-7. PubMed ID: 10073375
[TBL] [Abstract][Full Text] [Related]
16. A pharmacoeconomic evaluation of clozapine in one patient.
Rémillard AJ; Johnson JA
Can J Hosp Pharm; 1993 Jun; 46(3):115-9. PubMed ID: 10126866
[TBL] [Abstract][Full Text] [Related]
17. Methods of cost-effectiveness analysis in the evaluation of new antipsychotics: implications for schizophrenia treatment.
Neumann PJ
J Clin Psychiatry; 1999; 60 Suppl 3():9-14; discussion 15. PubMed ID: 10073371
[TBL] [Abstract][Full Text] [Related]
18. Dialogue. Prescription for problems? Capitating mental health drugs--the great debate.
Docherty JP; Browne RA; Farmer M
Behav Healthc Tomorrow; 1998 Oct; 7(5):32-8. PubMed ID: 10185199
[TBL] [Abstract][Full Text] [Related]
19. Pharmacoeconomics of schizophrenia in the 21st century.
Hanson MA
J Clin Psychiatry; 1999; 60 Suppl 1():26-7; discussion 28-30. PubMed ID: 10037168
[TBL] [Abstract][Full Text] [Related]
20. Outpatient antipsychotic treatment and inpatient costs of schizophrenia.
Marcus SC; Olfson M
Schizophr Bull; 2008 Jan; 34(1):173-80. PubMed ID: 17578893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
